论文部分内容阅读
目的:寻找更为有效的慢性胃炎临床治疗方法,为临床实践提供参考。方法:选择性的将84例慢性胃炎患者纳为研究对象,然后将他们划分为奥美拉唑治疗组与联合治疗组,每组人数42例。按照分组情况,对奥美拉唑治疗组患者给予奥美拉唑口服用药,对联合治疗组患者进一步加用法莫替丁进行联合口服用药。结果:从总的临床治疗有效率情况来看,联合治疗组高出奥美拉唑治疗组许多,对比差异非常显著,具有统计学意义,但不良反应发生率对比,两组却基本相当,对比差异并不明显,不具有统计学意义。结论:相比于奥美拉唑单独用药治疗而言,进一步联合法莫替丁对慢性胃炎患者进行治疗,可以取得更良好的治疗效果,且不会加重不良反应,值得加强推广实践。
Objective: To find a more effective clinical treatment of chronic gastritis, provide a reference for clinical practice. Methods: Eighty-four patients with chronic gastritis were selected as the study subjects, and then divided into two groups: omeprazole group and combination group, with 42 in each group. According to grouping, omeprazole was given orally to patients in the omeprazole group and to famotidine combined with oral orally in the combination therapy group. Results: From the total clinical treatment efficiency, the combination therapy group was higher than the omeprazole treatment group, the difference was significant, with statistical significance, but the incidence of adverse reactions, the two groups are basically the same, the contrast The difference is not obvious, not statistically significant. CONCLUSIONS: Compared with omeprazole alone, further combination of famotidine in treatment of patients with chronic gastritis can achieve better therapeutic effect without worsening adverse reactions, which is worth to strengthen the promotion of practice.